Univest
Univest
  • Markets

Shalby Limited vs Healthium Medtech: Share Price, PE, ROE Compared

  • August 12, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments

Shalby Limited MCap Rs 1,749 Cr, PE 50.45x, ROE 3.72%. Healthium Medtech MCap approx Rs 3,000-4,000 Cr (data approximate), surgical products company.

Shalby Limited vs Healthium Medtech is a comparison healthcare investors look up when evaluating two listed Indian companies at different parts of the healthcare value chain. Shalby Limited, a Ahmedabad-based company, is an orthopaedic hospital chain specialising in joint replacement and orthopaedic surgeries across Gujarat, Rajasthan and other states. Healthium Medtech, a Bengaluru-based company (owned by Apax Partners private equity), is a medical devices company making surgical sutures, wound care products and infection prevention materials. Comparing Shalby and Healthium Medtech covers hospitals versus surgical consumables.

This Shalby Limited vs Healthium Medtech article covers reach and market position, key products, latest declared results and stock valuation. All data is sourced from Groww and public company filings.

Table of Contents

Toggle
  • Reach and Market Position
  • Key Products and Business Mix
  • Latest Results and Financial Data
  • Stock Performance and Valuation
  • Shalby Limited vs Healthium Medtech: Quick Comparison Table
  • Conclusion
  • Frequently Asked Questions
    • What is Shalby Limited?
    • What does Healthium Medtech make?
    • What is joint replacement surgery?
    • Who owns Healthium Medtech?
    • Are Shalby and Healthium in Nifty 50?
    • Which is larger, Shalby or Healthium?
    • What are sutures in surgery?

Reach and Market Position

In this Shalby Limited vs Healthium Medtech comparison, Shalby operates orthopaedic-focused hospitals in Ahmedabad, Surat, Mumbai, Jaipur and other cities, serving orthopaedic surgery and joint replacement patients. Market capitalisation is Rs 1,749 Cr.

Click Here – Get Free Investment Predictions

Healthium Medtech manufactures surgical sutures, mesh, haemostats and wound care products distributed to hospitals and surgical centres across India and internationally. Market capitalisation is approximately Rs 3,000-4,000 Cr.

Key Products and Business Mix

For the Shalby Limited vs Healthium Medtech product breakdown, Shalby Limited: Shalby earns from orthopaedic hospital services – joint replacement (hip, knee), arthroscopy and spine surgeries. EPS is Rs 3.21. PE is 50.45x, ROE 3.72 percent, D/E 0.59.

Healthium Medtech: Healthium Medtech earns from branded surgical sutures and wound care medical devices. Data is approximate – verify current financials from exchange filings.

Latest Results and Financial Data

On the Shalby Limited vs Healthium Medtech results front: Shalby Limited has a market cap of Rs 1,749 Cr and PE of 50.45x. ROE is 3.72 percent. Shalby is a specialised orthopaedic hospital chain with a niche in joint replacement surgery.

Healthium Medtech has a market cap of approximately Rs 3,000-4,000 Cr. Healthium is a medical devices manufacturer. Investors should verify current financial data from exchange filings.

Compare Shalby Limited and Healthium Medtech Fundamentals on the Univest Screener

Stock Performance and Valuation

Investors tracking the Shalby Limited vs Healthium Medtech comparison should verify current prices on NSE or BSE before trading. The Shalby Limited vs Healthium Medtech stock data below reflects the latest available figures from Groww and public company filings.

Shalby versus Healthium Medtech: Shalby (Rs 1,749 Cr, hospitals, PE 50.45x) vs Healthium (approx Rs 3,000-4,000 Cr, surgical devices). The Shalby and Healthium comparison covers different healthcare business models.

Shalby Limited vs Healthium Medtech: Quick Comparison Table

The comparison table below summarises the key metrics side by side.

Parameter Shalby Limited Healthium Medtech
Sector Orthopaedic hospitals: joint replacement, spine surgery (Gujarat chain) Surgical consumables: sutures, mesh, haemostats, wound care (Apax PE-owned)
Market Cap Rs 1,749 Cr Approx Rs 3,000-4,000 Cr
P/E Ratio 50.45x Approx (verify from filings)
ROE 3.72% (thin) Approx (verify from filings)
Business Hospital chain (asset-heavy) Medical device manufacturing (B2B to hospitals)
Focus Orthopaedic surgeries (joint replacement speciality) Surgical consumables (sutures, wound care)
Ownership Promoter (Dr Vikram Shah family) Apax Partners (private equity)

Conclusion

The Shalby Limited vs Healthium Medtech comparison above covers reach, products, results and valuation. Shalby Limited versus Healthium Medtech covers an orthopaedic hospital chain versus a surgical consumables company. Shalby has a niche in joint replacement surgeries with India’s ageing population driving demand. Healthium serves hospitals with surgical products. The Shalby and Healthium comparison shows two healthcare companies at opposite ends of the care delivery chain. Consult a SEBI-registered advisor and verify current financials from exchange filings before any investment.

Download the Univest iOS App or Univest Android App to track Shalby Limited and Healthium Medtech live price and get daily stock recommendations.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is Shalby Limited?

Ans. Shalby Limited is an orthopaedic hospital chain based in Ahmedabad. It specialises in joint replacement (knee, hip, shoulder), arthroscopy and spine surgery – one of the highest-volume joint replacement hospitals in India.

What does Healthium Medtech make?

Ans. Healthium Medtech makes surgical sutures (absorbable and non-absorbable), surgical mesh (for hernia repair), haemostats (blood clotting agents) and wound care products used in hospitals and surgical centres.

What is joint replacement surgery?

Ans. Joint replacement involves replacing a damaged joint (typically knee or hip) with an artificial implant made of metal, ceramic and plastic. Shalby performs thousands of joint replacements annually at its hospitals.

Who owns Healthium Medtech?

Ans. Healthium Medtech is owned by Apax Partners, a global private equity firm that acquired the surgical products business from Strides Pharma.

Are Shalby and Healthium in Nifty 50?

Ans. Neither is in Nifty 50.

Which is larger, Shalby or Healthium?

Ans. Healthium Medtech at approximately Rs 3,000-4,000 Cr is larger than Shalby Limited at Rs 1,749 Cr.

What are sutures in surgery?

Ans. Sutures are medical threads used by surgeons to close wounds or join tissues during or after surgical operations. Healthium makes both absorbable sutures (which dissolve over time) and non-absorbable sutures.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply